Pharma Technology Focus is now available on all devices. Read it for free here.

The Pistoia Alliance has launched the User Experience for Life Sciences toolkit, designed to help pharma and biotech companies improve the user-friendliness of their software. We find out how poorly designed software can impact R&D, and how the toolkit could help.

We also consider the problem of unapproved and unregulated antibiotics being manufactured in India, investigate whether self-imposed price caps by some big pharma companies will be enough to keep drugs affordable, and find out more about Elsevier’s plans to create a new taxonomy for traditional Chinese medicine.

Finally, we take a look inside Canada’s Centre for Drug Research and Development as it works to solve unmet medical needs using innovative technologies, and unveil the six winning packaging systems at Pharmapack Europe 2018, which range from a motor-driven disposable auto-injector to an all-in-one contactless multi-dose delivery cap.

In this issue

Could focusing on the user experience reinvent drug R&D software?
Poorly designed software leads to frustrated scientists and an inefficient R&D process. Elly Earls finds out how the Pistoia Alliance is using user experience principles to tackle this issue and accelerate life sciences innovation.
Read the article here.

How India’s use of unapproved antibiotics could undermine global health
New research has shown that unapproved antibiotics are rife in India, undermining efforts to tackle antimicrobial resistance. Elly Earls meets Dr Patricia McGettigan to find out how the situation can be tackled.
Read the article here.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

View profiles in store

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Submit

UK USA Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo Democratic Republic of the Congo Cook Islands Costa Rica Côte d"Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates US Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam British Virgin Islands US Virgin Islands Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Kosovo

Industry * Academia & Education Aerospace, Defense & Security Agriculture Asset Management Automotive Banking & Payments Chemicals Construction Consumer Foodservice Government, trade bodies and NGOs Health & Fitness Hospitals & Healthcare HR, Staffing & Recruitment Insurance Investment Banking Legal Services Management Consulting Marketing & Advertising Media & Publishing Medical Devices Mining Oil & Gas Packaging Pharmaceuticals Power & Utilities Private Equity Real Estate Retail Sport Technology Telecom Transportation & Logistics Travel, Tourism & Hospitality Venture Capital

Tick here to opt out of curated industry news, reports, and event updates from Pharmaceutical Technology.

Submit and download

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

US drug pricing: could the industry regulate itself?
Pharmaceutical price hikes are nothing new, but increased criticism has instilled a new sense of social responsibility, at least for some companies. Chris Lo considers whether industry self-regulation could play a larger role in future US drug pricing.
Read the article here.

Unlocking the potential of Chinese medicine
With millions of Westerners using traditional medicines, global interest in Chinese elixirs is growing. Abi Millar finds out whether a new Elsevier database could help bridge the gap between traditional Chinese medicine and the Western pharma industry.
Read the article here.

Inside Canada’s Centre for Drug Research and Development
Canada’s Centre for Drug Research and Development has been working to grow and accelerate Canadian-based research. Abi Millar finds out more from Gordon McCauley, president and CEO.
Read the article here.

Award-winning pharma packaging
Pharmapack Europe has revealed the winners of the 2018 Pharmapack Awards. Elliot Gardner profiles the six winning packaging systems, from a motor-driven disposable auto-injector to an all-in-one contactless multidose delivery cap.
Read the article here.

Next issue preview

In the next special issue of Pharma Technology Focus, we take a closer look at some of the latest developments in biotechnology, including the revolutionary gene-editing tool CRISPR, which is quickly emerging as a key tool for drug target identification, as well as preclinical testing.

We also consider what regulatory steps need to be taken to improve the US adoption of biosimilars as it flags behind Europe, examine how the biotech M&A landscape is likely to develop over the course of 2018, as large pharma firms look to pad their pipelines with new acquisitions, and sit down with Dotmatics to find out more about the latest version of the company’s data visualisation tool Vortex.

Finally, we ask whether artificial intelligence can be used to extract genomic data and discover relevant biomarkers, and learn more about a new method of manufacturing proteins outside of a cell.